CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 115 enrolled
Drug / intervention
Dexamethasone +4 moredrug
Likely dose
Dexamethasone 8 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02464176
NCT02464176Phase 4Completed

The Effects of Systemic Steroids on the Duration of a Psoas Compartment Block.

Wake Forest University Health Sciences·interventional·Posted Jun 8, 2015·Updated Aug 31, 2018

In Brief

A Phase 4 clinical trial evaluating Dexamethasone, Bupivacaine, and 3 other interventions for Osteoarthritis, Hip. Completed, enrolled 115 participants across 1 site.

Detailed Summary

This study will investigate the ability of systemic dexamethasone to prolong the sensory block duration for lumbar plexus nerve blockade.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20162017201820192020202120222023202420252026
First PostedJun 8, 2015
Enrollment StartJun 1, 2015
Primary CompletionJan 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 11.1 years ago

Interventions

Dexamethasonedrug

A lumbar plexus nerve block will be performed for patients undergoing hip arthroplasty. A total of 25cc's of 0.25% bupivacaine with 1:400,000 epinephrine will be administered for postoperative analgesia. Surgical anesthesia will be provided either by an intrathecal spinal block or general anesthesia. Successful blockade will be assumed if the patient has a decrease or loss of pinprick sensation in the femoral nerve distribution, which innervates the anterior thigh. If no evidence of blockade is present, testing will occur again at 30 minutes post block. Testing will be performed with a 25 gauge Whitacre needle and once present the area of testing will be marked with a surgical marking pen so that repeat sensory testing can be undertaken at that same site over the course of the study. The subjects will then receive dexamethasone (4 or 8 mg) or placebo (saline) based on arm placement.

Bupivacainedrug

Bupivacaine will be used in lumbar plexus nerve block mixture.

Epinephrinedrug

Epinephrine will be used in lumbar plexus nerve block mixture.

Lumbar Plexus Nerve Blockprocedure

This is the procedure that will be performed.

Salinedrug

Patients randomized to the placebo group will receive normal saline intravenously.